| S7289 |
PFK-015
|
PFK15 (PFK-015) is a potent and selective 6-phosphofructo-2-kinase (PFKFB3) inhibitor with IC50 of 207 nM.
|
-
Nature, 2025, 10.1038/s41586-025-09328-w
-
Adv Healthc Mater, 2025, e2501417.
-
Cell Commun Signal, 2025, 23(1):104
|
|
| S7639 |
3PO
|
3PO (3-(3-pyridinyl)-1-(4-pyridinyl)-2-propen-1-one) is a small-molecule inhibitor of PFKFB3 with an IC50 of 22.9 μM for recombinant human PFKFB3 protein and does not inhibit PFK-1 activity. It suppresses glucose uptake, and decreases the intracellular concentration of Fru-2,6-BP, lactate, ATP, NAD+, and NADH.
|
-
Atherosclerosis, 2025, 405:119223
-
bioRxiv, 2025, nan
-
J Transl Med, 2024, 22(1):954
|
|
| S8807 |
PFK158
|
PFK158 is a potent and selective inhibitor of PFKFB3. It has improved PK properties and causes ~80% growth inhibition in several mouse models of human-derived tumors.
|
-
Cancer & Metabolism, September 23, 2021, 33
-
eLife, September 09, 2025, 107536
-
Frontiers in Cellular and Infection Microbiology, October 08, 2025, 1648576
|
|
| S0400 |
KAN0438757
|
KAN0438757 is a potent and selective inhibitor of the metabolic kinase PFKFB3 (6-Phosphofructo-2-Kinase/Fructose-2,6-Biphosphatase 3) with IC50 of 0.19 μM and 3.6 μM for PFKFB3 and PFKFB4, respectively.
|
-
Current Issues in Molecular Biology, 2025, 892
-
Molecular & Cellular Proteomics, 2023, 100649
-
Mol Cell Proteomics, 2023, 22(11):100649
|
|